Globus Medical, Inc. Share Price
Equities
GMED
US3795772082
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 80.00 USD | 0.00% |
|
-2.30% | -8.37% |
| Capitalization | 1.09TCr 940.44Cr 862.91Cr 811.86Cr 1.51TCr 1,03500Cr 1.54TCr 10TCr 3.99TCr 50TCr 4.08TCr 3.99TCr 1,74000Cr | P/E ratio 2026 * |
20.3x | P/E ratio 2027 * | 18.4x |
|---|---|---|---|---|---|
| Enterprise value | 1.09TCr 940.44Cr 862.91Cr 811.86Cr 1.51TCr 1,03500Cr 1.54TCr 10TCr 3.99TCr 50TCr 4.08TCr 3.99TCr 1,74000Cr | EV / Sales 2026 * |
3.39x | EV / Sales 2027 * | 3.19x |
| Free-Float |
82.93% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Globus Medical, Inc.
| 1 week | -2.30% | ||
| Current month | -2.30% | ||
| 1 month | -11.14% | ||
| 3 months | -10.40% | ||
| 6 months | -12.18% | ||
| Current year | -8.37% |
| 1 week | 77.41 |  | 81.68 |
| 1 month | 74.5 | | 91.44 |
| Current year | 74.5 | | 101.4 |
| 1 year | 51.79 | | 101.4 |
| 3 years | 43.38 | | 101.4 |
| 5 years | 43.38 | | 101.4 |
| 10 years | 19.25 | | 101.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Keith Pfeil
CEO | Chief Executive Officer | 47 | 18/07/2025 |
Kyle Kline
DFI | Director of Finance/CFO | 41 | 18/07/2025 |
Brian Kearns
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Paul
CHM | Chairman | 59 | 01/01/2003 |
David Davidar
BRD | Director/Board Member | 60 | 01/01/2003 |
Daniel Lemaitre
BRD | Director/Board Member | 72 | 21/04/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/02 | Fiscal year | General Counsel | 60,000 | 0.0535% | ||
| 12/02 | Fiscal year | General Counsel | 30,000 | 0.0267% | ||
| 21/01 | Free | Director | 15,000 | 0.0134% |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -2.30% | +34.34% | +44.25% | 1.09TCr | |
| +0.32% | +6.39% | -32.01% | -12.23% | 16TCr | |
| -0.32% | +10.65% | -6.13% | -2.46% | 10TCr | |
| -0.34% | -2.73% | +60.07% | +43.78% | 5.5TCr | |
| +1.75% | +2.11% | -4.64% | +57.44% | 5.35TCr | |
| +1.07% | +2.75% | -11.62% | -40.49% | 4.17TCr | |
| -2.44% | -8.07% | - | - | 2.84TCr | |
| +0.37% | -1.19% | -15.02% | -41.55% | 2.81TCr | |
| -0.89% | -2.57% | +43.88% | -8.42% | 2.22TCr | |
| +0.18% | -5.04% | -12.24% | +2.61% | 2.1TCr | |
| Average | -0.03% | -0.06% | +6.29% | +4.77% | 5.24TCr | |
| Weighted average by Cap. | +0.12% | +3.27% | -5.00% | +1.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 320.31Cr 277.39Cr 254.52Cr 239.46Cr 446Cr 31TCr 452.98Cr 3.03TCr 1.18TCr 15TCr 1.2TCr 1.18TCr 51TCr | 340.83Cr 295.16Cr 270.83Cr 254.81Cr 474.58Cr 32TCr 482.01Cr 3.22TCr 1.25TCr 16TCr 1.28TCr 1.25TCr 55TCr |
| Net income | 55Cr 48Cr 44Cr 41Cr 77Cr 5.24TCr 78Cr 519.54Cr 202.2Cr 2.53TCr 206.54Cr 202.05Cr 8.82TCr | 61Cr 53Cr 48Cr 45Cr 85Cr 5.79TCr 86Cr 574.09Cr 223.43Cr 2.8TCr 228.23Cr 223.26Cr 9.74TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/26/05 | 80.00 $ | 0.00% | 15,95,511 |
| 04/26/04 | 80.00 $ | +2.63% | 13,28,186 |
| 03/26/03 | 77.95 $ | -0.38% | 16,21,934 |
| 02/26/02 | 78.25 $ | -1.92% | 17,66,191 |
| 01/26/01 | 79.78 $ | -2.56% | 19,21,560 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GMED Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition